NCT06443320 Evaluation of the Videodrama Therapeutic Device for Children With Autism Spectrum Disorders
| NCT ID | NCT06443320 |
| Status | Recruiting |
| Phase | — |
| Sponsor | Centre Hospitalier Intercommunal Robert Ballanger |
| Condition | Autism Spectrum Disorder (ASD) |
| Study Type | INTERVENTIONAL |
| Enrollment | 30 participants |
| Start Date | 2023-12-04 |
| Primary Completion | 2027-03-04 |
Eligibility & Interventions
Eligibility Fast-Check
Enter your details for a quick preliminary check. This does not replace medical advice.
What to Expect as a Participant
You will actively receive the study intervention — which may be a drug, biologic, device, or procedure.
This trial targets 30 participants in total. It began in 2023-12-04 with a primary completion date of 2027-03-04.
⚠ This information is for research awareness only. Always consult your physician before joining any clinical trial. Participation is voluntary and you may withdraw at any time.
Brief Summary
Autism spectrum disorder (ASD) is a neurodevelopmental disorder (Valerie, Sperenza, 2009) that begins early in development, characterized by persistent deficits in communication and social interactions across various contexts and restricted, repetitive patterns of behavior, interests, or activities. These symptoms significantly impact social, school/professional functioning, or other important areas and are not better explained by intellectual disability or global developmental delay (American Psychiatric Association, 2013).
Eligibility Criteria
Inclusion Criteria: * Children aged 3 to 15 years. * Clinically confirmed ASD by a psychiatrist. * Parental or legal guardian consent for participation. * Child showing a strong interest in screens and/or video content. * Ability to tolerate the presence of other children. * Minimum of 18 video drama sessions. * Not having benefited from disease care in the past. * Affiliation to a social security system Exclusion Criteria: * No ASD diagnosis. * Younger than 3 or older than 15 at the study start. * No interest in screens or video content. * Parental or legal guardian refusal for participation. * Dropping out before completing 18 sessions. * Patient having benefited a disease care in the past
Contact & Investigator
Frequently Asked Questions
Who can join the NCT06443320 clinical trial?
This trial is open to participants of all sexes, aged 3 Years or older, up to 15 Years, studying Autism Spectrum Disorder (ASD). Full inclusion and exclusion criteria are listed in the Eligibility Criteria section. Always confirm your eligibility with the research team before applying.
Is NCT06443320 currently recruiting?
Yes, NCT06443320 is actively recruiting participants. Contact the research team at constance.lemarchand@ght-gpne.fr for enrollment information.
Where is the NCT06443320 trial being conducted?
This trial is being conducted at Aulnay-sous-Bois, France.
Who is sponsoring the NCT06443320 clinical trial?
NCT06443320 is sponsored by Centre Hospitalier Intercommunal Robert Ballanger. The trial plans to enroll 30 participants.